CTOs on the Move

IntegraCare Home health

www.txhmg.com

 
IntegraCare Home health is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Grapevine, TX. To find more information about IntegraCare Home health, please visit www.txhmg.com
  • Number of Employees: 0-25
  • Annual Revenue: $250-500 Million
  • www.txhmg.com
  • 2559 SW Grapevine Pkwy Ste 300
    Grapevine, TX USA 76051-1000
  • Phone: 817.310.4900

Executives

Name Title Contact Details

Similar Companies

Wilson Ophthalmic Corp

Wilson Ophthalmic Corp is a Mustang, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vitalah

Oxylent has taken the multivitamin category by storm with its award-winning 5-in-1 formula that delivers vitamins, minerals, antioxidants, amino acids and electrolytes in one refreshing drink. Without the use of sugar, gluten, artificial additives, preservatives, dairy, caffeine, binders, or anti-caking agents, Oxylent is known in the market for using only the highest quality ingredients. Oxylent is the only effervescent multivitamin to be awarded Albion’s Gold Medallion, recognizing excellence in mineral formulation. The product contains no sugar and is sweetened with all-natural stevia, a plant-based sweetener that provides the sweetness of sugar without the calories or increase in blood sugar levels. Plus, Oxylent is 100 percent free of gluten, dairy, soy, GMOs and caffeine.

Marcon Group Inc

Marcon Group Inc is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nature Coast Lodge

Nature Coast Lodge is a Lecanto, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.